1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase 2 clinical trial of olaratumab in combination with gemcitabine and docetaxel in advanced soft tissue sarcomas
    Journal Article

    Attia, S.; Villalobos, V.; Hindi, N.; Wagner, A. J.; Chmielowski, B.; Oakley, G. J. 3rd; Peterson, P. M.; Ceccarelli, M.; Jones, R. L.; Dickson, M. A.
    Cancers (2023)

    Fulltext@MSK | Save
  • Neuroimaging and neurocognitive outcomes in older patients with multiple myeloma treated with chemotherapy and autologous stem cell transplantation
    Journal Article

    Correa, D. D.; Vachha, B. A.; Baser, R. E.; Koch, A.; Wong, P.; Gohel, S.; Giralt, S.; Root, J. C.
    Cancers (2023)

    Fulltext@MSK | Save
  • GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS©): Psychometric properties and clinically meaningful thresholds as assessed in the phase 3 DeFi randomized controlled clinical trial
    Journal Article

    Gounder, M. M.; Atkinson, T. M.; Bell, T.; Daskalopoulou, C.; Griffiths, P.; Martindale, M.; Smith, L. M.; Lim, A.
    Quality of Life Research (2023)

    Fulltext@MSK | Save
  • Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma
    Journal Article

    Grommes, C.; Pentsova, E.; Schaff, L. R.; Nolan, C. P.; Kaley, T.; Reiner, A. S.; Panageas, K. S.; Mellinghoff, I. K.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Prospective feasibility and phase 1/2 trial of preoperative proton beam therapy with concurrent chemotherapy for resectable stage IIIA or superior sulcus non-small cell lung cancer
    Journal Article

    Simone, C. B. 2nd; Yegya-Raman, N.; Manjunath, S.; Verma, V.; Shabason, J. E.; Xu, L.; Cengel, K. A.; Levin, W. P.; Berman, A. T.; Christodouleas, J. P.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Short report of a phase ii trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
    Journal Article

    Wozniak, A. J.; Schneider, B.; Kalemkerian, G. P.; Daly, B.; Chen, W.; Ventimiglia, J.; Nagasaka, M.; Zauderer, M. G.
    Clinical Lung Cancer (2023)

    Fulltext@MSK | Save
  • A comparison of brief versus explicit descriptors for verbal rating scales: Interrupted time series design
    Journal Article

    Vickers, A. J.; Assel, M.; Hannon, M.; Desai, P.; Carlsson, S. V.; McCready, T.; Cracchiolo, J.; Simon, B.
    Health and Quality of Life Outcomes (2023)

    Fulltext@MSK | Save
  • Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
    Journal Article

    Pignata, S.; Bookman, M.; Sehouli, J.; Miller, A.; Penson, R. T.; Taskiran, C.; Anderson, C.; Hietanen, S.; Myers, T.; Madry, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Asciminib in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia: Focus on patient selection and outcomes
    Review

    Hijiya, N.; Mauro, M. J.
    Cancer Management and Research (2023)

    Fulltext@MSK | Save
  • Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
    Journal Article

    Roeker, L. E.; DerSarkissian, M.; Ryan, K.; Chen, Y.; Duh, M. S.; Wahlstrom, S. K.; Hakre, S.; Yu, L.; Guo, H.; Mato, A. R.
    Blood Advances (2023)

    Fulltext@MSK | Save